Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

[1]  A. Lopes,et al.  Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps , 2018, Pathology & Oncology Research.

[2]  M. Reni,et al.  Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. , 2017, Cancer treatment reviews.

[3]  K. Jirström,et al.  Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer. , 2017, European journal of cancer.

[4]  Melvin E. Andersen,et al.  Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts , 2017, Critical reviews in toxicology.

[5]  Sheng Zhou,et al.  Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer , 2017, OncoTarget.

[6]  G. Botti,et al.  Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials , 2017, Acta oncologica.

[7]  E. Richardsen,et al.  Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer , 2016, Steroids.

[8]  L. Wood,et al.  Pancreatic cancer , 2016, The Lancet.

[9]  Qingqing Zhu,et al.  Prognostic value of the expression of estrogen receptor β in patients with non-small cell lung cancer: a meta-analysis. , 2016, Translational lung cancer research.

[10]  Y. Niv.  Estrogen receptor &bgr; expression and colorectal cancer: a systematic review and meta-analysis , 2015, European journal of gastroenterology & hepatology.

[11]  A. Marx,et al.  Expression of oestrogen receptor β and prognosis of colorectal cancer , 2012, British Journal of Cancer.

[12]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[13]  Gang Li,et al.  Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials. , 2011, Surgery.

[14]  J. Shen,et al.  Prognostic Role of Estrogen Receptor α and Estrogen Receptor β in Gastric Cancer , 2010, Annals of Surgical Oncology.

[15]  J. Carrier,et al.  Estrogen receptor β deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice , 2008, International journal of cancer.

[16]  N. Ananthakrishnan,et al.  Estrogen and progesterone receptors in esophageal carcinoma. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[17]  D. Malkin,et al.  The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifen. , 2008, Cancer research.

[18]  C. Verbeke,et al.  Variability in reporting resection margin status in pancreatic cancer. , 2008, Annals of surgery.

[19]  Rachel Schiff,et al.  Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. , 2008, Endocrine reviews.

[20]  R. Santen,et al.  Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. , 2007, Endocrinology.

[21]  Maria Marino,et al.  17β-Estradiol induces ERβ up-regulation via p38/MAPK activation in colon cancer cells , 2007 .

[22]  T. Oyama,et al.  Significance of Immunohistochemical Expression of Estrogen Receptors α and β in Squamous Cell Carcinoma of the Esophagus , 2007, Clinical Cancer Research.

[23]  Margaret Warner,et al.  Estrogen receptors: how do they signal and what are their targets. , 2007, Physiological reviews.

[24]  R. Schwarz,et al.  Estrogen Receptor β/α Ratio Predicts Response of Pancreatic Cancer Cells to Estrogens and Phytoestrogens , 2007 .

[25]  L. Saal,et al.  Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma , 2007, Clinical Cancer Research.

[26]  M. Fishbein,et al.  Estrogen receptor signaling pathways in human non-small cell lung cancer , 2007, Steroids.

[27]  V. Go,et al.  Estrogen Receptors in Pancreatic Tumors , 2006, Pancreas.

[28]  E. Leygue,et al.  Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours , 2006, British Journal of Cancer.

[29]  R. Wolff,et al.  Associations between ERα, ERβ, and AR Genotypes and Colon and Rectal Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[30]  S. Fosså,et al.  Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma , 2005, International journal of cancer.

[31]  A. Gozzini,et al.  ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. , 2005, Endocrine-related cancer.

[32]  Heidi L. Weiss,et al.  Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer , 2004, Clinical Cancer Research.

[33]  M. Shupnik.  Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation , 2004, Oncogene.

[34]  M. Colombo,et al.  The clinical and pathogenetic significance of estrogen receptor‐β expression in chronic liver diseases and liver carcinoma , 2003, Cancer.

[35]  A. Papavassiliou,et al.  Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. , 2003, European journal of cancer.

[36]  M. Tsuneyoshi,et al.  Mucinous cystic tumor of the pancreas: immunohistochemical assessment of "ovarian-type stroma". , 2003, Oncology reports.

[37]  A. Colantoni,et al.  Estrogen receptor classification for hepatocellular carcinoma: comparison with clinical staging systems. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Y. Jan,et al.  Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma , 2002, Gut.

[39]  A. Zullo,et al.  A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer. , 2002, Anticancer research.

[40]  Y. Miyoshi,et al.  Quantitative analysis of estrogen receptor-α and -β messenger RNA expression in human pancreatic cancers by real-time polymerase chain reaction , 2001 .

[41]  Simak Ali,et al.  Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α , 2001, The Journal of Biological Chemistry.

[42]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[43]  R. Poulsom,et al.  Expression of oestrogen receptor and oestrogen‐inducible genes in pancreatic cancer , 1997, The British journal of surgery.

[44]  J. Gustafsson,et al.  The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens , 1997, FEBS letters.

[45]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[46]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[47]  Ollayos Cw,et al.  Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. , 1994 .

[48]  A. Wong,et al.  Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case‐control study , 1993, Cancer.

[49]  O. M. Taylor,et al.  Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma , 1993, The British journal of surgery.

[50]  W. Remmele,et al.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.

[51]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[52]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[53]  N. Bardeesy,et al.  Pancreatic adenocarcinoma. , 2014, The New England journal of medicine.

[54]  T. Oyama,et al.  Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

[55]  R. Schwarz,et al.  Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens. , 2007, The Journal of surgical research.

[56]  Maria Marino,et al.  17Beta-estradiol induces ERbeta up-regulation via p38/MAPK activation in colon cancer cells. , 2007, Biochemical and biophysical research communications.

[57]  Wolfgang Schima,et al.  Pancreatic adenocarcinoma , 2006, European Radiology.

[58]  R. Wolff,et al.  Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[59]  Y. Miyoshi,et al.  Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in human pancreatic cancers by real-time polymerase chain reaction. , 2001, Cancer letters.

[60]  I. J. Lynch,et al.  Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer. , 2001, Cancer research.

[61]  R. Becker,et al.  Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases. , 1999, The American journal of surgical pathology.

[62]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[63]  J. Polman,et al.  ER beta: identification and characterization of a novel human estrogen receptor. , 1996, FEBS letters.

[64]  G. Riordan,et al.  Estrogen receptor detection in paraffin sections of adenocarcinoma of the colon, pancreas, and lung. , 1994, Archives of pathology & laboratory medicine.

[65]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.